Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled HIV-1 Infection
Clinical Infectious Diseases · 2026
DOI: 10.1093/cid/ciaf537 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Patricia Martínez-Martín und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Infectious Diseases Unit, La Paz University Hospital, Madrid, Spain. Hauptthemen laut MEDLINE: HIV Infections, Aging, Epigenesis, Genetic, Biomarkers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Instituto de Salud Carlos III-European Regional Development, Instituto de Salud Carlos III-Fondo Social Europeo, Instituto de Salud Carlos III–European Regional Development.
Abstract (Originalsprache)
Background
Epigenetic age acceleration (EAA) predicts morbidity and mortality in the general population, but its prognostic utility in people with human immunodeficiency virus (HIV) (PWH) on suppressive antiretroviral therapy remains unclear.
Methods
Longitudinal observational cohort of 216 PWH with sustained virological suppression (median 6.5 years) recruited from the DUAL-GESIDA trial and La Paz Aging Cohort (Spain). Baseline blood DNA methylation was assessed to evaluate 8 epigenetic clocks, their principal-component (PC) derivatives, and the telomere length estimator. Over 10 years, we recorded AIDS, serious non-AIDS (SNAEs), and aging-related events. Associations between EAA and outcomes were evaluated by multivariate Cox models.
Results
One hundred five participants experienced ≥ 1 event, 162 events recorded in total (1 AIDS event, 65 SNAEs, and 96 aging-related events). A positive EAA by Horvath's clock was associated with a 50% higher risk of aging-related events. Participants with positive EAA according to PC-GrimAge, GrimAge V1-V2, as well as Hannum´s clock experienced more than 2-fold increased risk of SNAEs. Positive EAA by PC-GrimAge and PhenoAge was associated with an increased risk of non-AIDS cancer. Additionally, positive EAA according to GrimAge V1-V2 was linked to a 4-fold increase in all-cause mortality risk. All individuals who died (n = 17) had a baseline DunedinPACE value >1. No associations were found for the composite endpoint or cardiovascular events.
Conclusions
In this preliminary study, GrimAge and PC-GrimAge were associated with increased risk of adverse outcomes in people with well-controlled HIV infection. These findings suggest their potential as long-term health-risk biomarkers, warranting validation in larger cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Infectious Diseases Unit, La Paz University Hospital, Madrid, Spain.
- Hospital La Paz Institute for Health Research (IdiPAZ), HIV/AIDS and Infectious Diseases Research Group, Madrid, Spain.
- CIBER of Infectious Diseases (CIBERINFEC), Madrid, Spain.
- Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre and CIBERONC, Madrid, Spain.
- Department of Internal Medicine-HIV Unit, Hospital 12 de Octubre, Madrid, Spain.
- Department of Internal Medicine, Infectious Diseases Unit, Hospital Universitario Príncipe de Asturias. Alcalá de Henares, Madrid, Spain.
ORCID-Profile: Patricia Martínez-Martín, Alejandro de Gea Grela, Alejandro Díez Vidal, María Del Mar Arcos-Rueda, Jose I Bernardino, María de Lagarde, José Sanz-Moreno, Pablo Ryan, Vicente Estrada Pérez, Juan Emilio Losa-García, José R Arribas
Förderung
- Instituto de Salud Carlos III-European Regional Development
- Instituto de Salud Carlos III-Fondo Social Europeo
- Instituto de Salud Carlos III–European Regional Development
Zitieren
APA
Martínez-Martín, P., Esteban-Cantos, A., Jurado, F., Montejano, R., Gutiérrez-García, L., de Gea Grela, A., González, J. C., Marcelo, C., Díez Vidal, A., Arcos-Rueda, M. D. M., De Miguel Buckley, R., Bernardino, J. I., Jiménez-González, M., de Lagarde, M., Sanz-Moreno, J., Ryan, P., Estrada Pérez, V., Pérez-Latorre, L., Losa-García, J. E., …, & Arribas, J. R. (2026). Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled HIV-1 Infection. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf537
Vancouver
Martínez-Martín P, Esteban-Cantos A, Jurado F, Montejano R, Gutiérrez-García L, de Gea Grela A, et al. Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled HIV-1 Infection. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf537
BibTeX
@article{MartnezMartn2026,
author = {Martínez-Martín, Patricia and Esteban-Cantos, Andrés and Jurado, Francisco and Montejano, Rocío and Gutiérrez-García, Lucía and de Gea Grela, Alejandro and González, Juan Carlos and Marcelo, Cristina and Díez Vidal, Alejandro and Arcos-Rueda, María Del Mar and De Miguel Buckley, Rosa and Bernardino, Jose I and Jiménez-González, María and de Lagarde, María and Sanz-Moreno, José and Ryan, Pablo and Estrada Pérez, Vicente and Pérez-Latorre, Leire and Losa-García, Juan Emilio and Rodés, Berta and Arribas, José R},
title = {Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled HIV-1 Infection},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciaf537}
}
EUVIMED